An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile

por Gan, Xin, Shan, Qianqian, Li, He, Janssens, Rick, Shen, Yuqiang, He, Yun, Chen, Fei, van Haperen, Rien, Drabek, Dubravka, Li, Jin, Zhang, Yang, Zhao, Jiuqiao, Qin, Beibei, Jheng, Ming-Jin, Chen, Victor, Wang, Jingsong, Rong, Yiping, Grosveld, Frank
Publicado 2022